The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia

OBJECTIVE: To determine the effects of the platelet-specific nitric oxide donor S-nitrosoglutathione on women with severe preeclampsia. METHODS: Ten women with severe preeclampsia or preeclampsia with severe fetal compromise at 21-33 weeks' gestation each received a 60-90-minute intravenous infusion of 50-250 micrograms/minute of S-nitrosoglutathione. Each was hypertensive, despite conventional oral antihypertensive therapy in eight. Maternal blood pressure, heart rate, platelet activation, uterine artery, and fetal Doppler indices were measured during the infusion. RESULTS: A dose-dependent reduction in mean arterial pressure from 125 mmHg (95% confidence interval [CI] 117-133) to 103.5 (95% CI 97-111) (P < .005) and an increase in pulse rate from 73.7 beats per minute (95% CI 64.3-84.5) to 89.1 (95% CI 81.2-97.8) (P < .02) was observed during the infusion. Mean uterine artery resistance index fell from 0.76 (95% CI 0.73-0.81) to 0.70 (95% CI 0.65-0.75) (P < .009). Platelet activation measured by P-selectin expression was reduced from 3.02% (95% CI 2.09-4.36) to 1.22% (95% CI 0.94-1.58) (P < .01). Fetal Doppler indices (umbilical artery, middle cerebral artery, and thoracic aorta) showed no significant changes during the infusion. CONCLUSION: S-nitrosoglutathione infusion reduced material mean arterial pressure, platelet activation, and uterine artery resistance without further compromising fetal Doppler indices. This study suggests that platelet-specific nitric oxide donors may prove beneficial in the management of severe preeclampsia.

This article has been cited by other articles:

				F. B. Pipkin and on behalf of The Genetics of Preeclampsia Consorti Smoking in Moderate/Severe Preeclampsia Worsens Pregnancy Outcome, but Smoking Cessation Limits the Damage Hypertension, April 1, 2008; 51(4): 1042 - 1046. [Abstract] [Full Text] [PDF]

				I. Thaler and H. Kahana The Effect of a Nitric Oxide Donor on Fetal Heart Rate Patterns in Patients With Hypertension Obstet. Gynecol., November 1, 2002; 100(5): 987 - 991. [Abstract] [Full Text] [PDF]

				D. O. C. Anumba, S. C. Robson, R. J. Boys, and G. A. Ford Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H848 - H854. [Abstract] [Full Text] [PDF]

				F. Facchinetti, M. Longo, F. Piccinini, I. Neri, and A. Volpe L-Arginine Infusion Reduces Blood Pressure in Preeclamptic Women Through Nitric Oxide Release Reproductive Sciences, July 1, 1999; 6(4): 202 - 207. [Abstract] [PDF]

				J. M A Teixeira, N. M Fisk, and V. Glover Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study BMJ, January 16, 1999; 318(7177): 153 - 157. [Abstract] [Full Text]

				A. Gries, C. Bode, K. Peter, A. Herr, H. Bohrer, J. Motsch, and E. Martin Inhaled Nitric Oxide Inhibits Human Platelet Aggregation, P-Selectin Expression, and Fibrinogen Binding In Vitro and In Vivo Circulation, April 21, 1998; 97(15): 1481 - 1487. [Abstract] [Full Text] [PDF]